Reaction of Indian Gold Exchange Traded Funds to Covid-19 Cases and Fatalities
DOI:
https://doi.org/10.21632/irjbs.14.3.187-198Keywords:
ARDL, Covid-19, ETFs, Fatalities, LockdownAbstract
Exchange Traded Funds (ETFs) are recently popularised new form of financial market instruments that provide benefit of both mutual funds and stocks. Present study investigated if there exists any difference between the average returns of selected Gold ETFs during Covid-19 era against pre Covid-19 era and subsequently analysed the long term and short term impact of new Covid-19 cases and fatalities on returns of Gold ETFs through Auto-regressive distributed lag (ARDL) model. It has been observed that in long term new Covid-19 cases had positive and significant impact on the returns of ETFs while new fatalities had significant negative impact on the returns of all the Gold ETFs except for BSLGOLD ETF. Short-run relationship between dependent and independent variables was in contrast to the long-term relationship
References
Al-Awadhi et. al(2020).Death and contagious infectious diseases: Impact of the Covid-19 virus on stock market returns. Journal of behavioral and experimental finance, 27.doi :https://doi.org/10.1016/j.jbef.2020.100326.
Alfaro, L., et. al(2020).Aggregate and firm-level stock returns during pandemics, in real time (No. w26950).National Bureau of Economic Research.
Aravind, M., &Manojkrishnan, C.(2020).Covid-19: Effect on leading pharmaceutical stocks listed with NSE. International Journal of Research in Pharmaceutical Sciences, 11,31-36.
Ashraf, Badar. Nadeem(2020).Stock markets’ reaction to Covid-19: cases or fatalities?. Research in International Business and Finance.doi: https://doi.org/10.1016/j.ribaf.2020.101249.
Baret, S., et.al.(2020).Covid-19 potential implications for the banking and capital markets sector. Maintaining Business and Operational Resilience. Deloitte Insights.
Gates, B.(2020).Responding to Covid-19—a once-in-a-century pandemic?. The New England Journal of Medicine, 382(18), (2020), 1677-1679.doi: 10.1056/NEJMp200376.
Khan, K. et. al.(2020).The impact of Covid-19 pandemic on stock markets: An empirical analysis of world major stock indices. The Journal of Asian Finance, Economics, and Business, 7(7),463-474.doi:10.13106/jafeb.2020.vol7.no7.463.
Ozili, P. K., & Arun, T .(2020).Spillover of Covid-19: Impact on the Global Economy. Available at SSRN 3562570.,1-27.
Pesaran, M. Hashem, et al.(2001).Bounds testing approaches to the analysis of level relationships.Journal of applied econometrics,16(3), 289-326.
Rajamohan, S., Sathish, A., & Rahman, A (2020).Impact of Covid-19 on stock price of NSE in automobile sector.Int. J.Adv. Multidiscip. Res, 7(7),(2020),24-29.doi: 10.22192/ijamr.
Ramelli, Stefano, and Alexander F. Wagner(2020).Feverish stock price reactions to Covid-19.The Review of Corporate Finance Studies 9(3),622-655.doi: https://doi.org/10.1093/rcfs/cfaa012.
Sansa, Nuhu. A.(2020).The Impact of the Covid-19 on the Financial Markets: Evidence from China and USA.Electronic Research Journal of Social Sciences and Humanities, 2(II),29-39.
Topcu, Mert, and Omer Serkan Gulal (2020).The impact of Covid-19 on emerging stock markets. Finance Research Letters”, 36. doi: doi: https://doi.org/10.1016/j.frl.2020.101691.
Downloads
Submitted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ashima Gaba, Ravinder Kumar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Journal Author(s) Rights
For IRJBS to publish and disseminate research articles, we need publishing rights (transferred from the author(s) to the publisher). This is determined by a publishing agreement between the Author(s) and IRJBS. This agreement deals with the transfer or license of the copyright of publishing to IRJBS, while Authors still retain significant rights to use and share their own published articles. IRJBS supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.
As a journal Author, you have rights to many uses of your article, including use by your employing institute or company. These Author rights can be exercised without the need to obtain specific permission. Authors publishing in IRJBS journals have comprehensive rights to use their works for teaching and scholarly purposes without needing to seek permission, including:
- use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees;
- use for internal training by the author's company;
- distribution to colleagues for their research use;
- use in a subsequent compilation of the author's works;
- inclusion in a thesis or dissertation;
- reuse of portions or extracts from the article in other works (with full acknowledgment of the final article);
- preparation of derivative works (other than commercial purposes) (with full acknowledgment of the final article);
- voluntary posting on open websites operated by the author or the author’s institution for scholarly purposes,
(But it should follow the open access license of Creative Common CC-by-SA License).
Authors/Readers/Third Parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, even commercially. Still, they must give appropriate credit (the name of the creator and attribution parties (authors' detail information), a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made (Publisher indicates the modification of the material (if any) and retain an indication of previous modifications.
Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
